Nausea And Vomiting clinical trials

Explore recruiting nausea and vomiting clinical trials.

Recruiting nausea and vomiting studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nausea And Vomiting trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The efficacy of aprepitant for the prevention of postoperative nausea and vomiting after bariatric surgery.

Estonia

Therapeutic use (Phase IV) EU CTIS Study details

A prospective, multicentre open-label clinical trial to evaluate the efficacy of the fixed-dose combination of Doxylamine and Pyridoxine 10/10 mg modified-release capsules on the quality of life of pregnant women presenting with nausea and vomiting of pregnancy (NVP).

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, double-blind, Phase 2/3 study of IV amisulpride as prevention of post-operative nausea and vomiting in pediatric patients

France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

DAVINCY trial: optimal Duration of (fos)Aprepitant prophylaxis for nausea and Vomiting INduced by ChemotherapY in children: a double-blind placebo-controlled crossover randomized phase III trial.

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Postoperative recovery with the addition of long-acting NK1- and 5-HT3 receptor antagonists as prophylaxis for post-operative nausea and vomiting. A prospective, double-blind, randomized trial in laparoscopic surgery.

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicenter, multinational, pharmacokinetic, safety, and efficacy study with IV NEPA (fosnetupitant/palonosetron) for the prevention of chemotherapy-induced nausea and vomiting in pediatric cancer patients undergoing highly emetogenic chemotherapy (HEC). A 2-part study with Phase 2, open-label, randomized, single-dose IV NEPA vs fosaprepitant/ondansetron in single-day HEC and repeated-dose IV NEPA in multi-day HEC (Part I, single cycle) and with Phase 3, double-blind, randomized, repeated-dose IV NEPA vs aprepitant/ondansetron in multi-day HEC (Part II, repeated cycles).

Poland, Greece, Romania

Phase II and Phase III (Integrated) EU CTIS Study details

Nausea And Vomiting trials by city

Nausea And Vomiting in Toronto Nausea And Vomiting in Vancouver Nausea And Vomiting in Montreal Nausea And Vomiting in Calgary Nausea And Vomiting in Edmonton Nausea And Vomiting in Ottawa Nausea And Vomiting in Winnipeg Nausea And Vomiting in Quebec City Nausea And Vomiting in Hamilton Nausea And Vomiting in Kitchener Nausea And Vomiting in London Nausea And Vomiting in Halifax Nausea And Vomiting in New York Nausea And Vomiting in Los Angeles Nausea And Vomiting in Chicago Nausea And Vomiting in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease